« Back to Press Releases & Article Home

Are Generic Drugs unsafe?
Most people believe that Generic drugs are unsafe, not helpful as brand names for your diseases; they are made in unauthorized facilities etc.....

Distribution Source : Finegenerics
Date : Monday, 12 Dec. 2005

Most people believe that Generic drugs are unsafe, not helpful as brand names for your diseases; they are made in unauthorized facilities etc. But this is not the truth, The standards for quality are the same for brand name and generic products.

'Generic Drugs' are prescription drugs which have the same - active ingredient formula as a brand name drug. A generic drug is a copy that is the same as a brand-name drug in dosage, safety, and strength, how it is taken, quality, performance, and intended use. The original manufacturer of a drug receives a patent on the drug and is the only manufacturer who can produce and sell the drug during this patent period. Once the patent expires, other manufacturers may produce and sell the drug.

Generic drugs are safe and effective as brand-name drugs. Generic drugs are only cheaper because the manufacturers have not had the expenses of developing and marketing a new drug. There’s no truth in the myths that generic drugs are manufactured in poorer-quality facilities or are not as good as in quality to brand-name drugs. Trademark laws do not allow the generic drugs to look exactly like the brand-name drugs, but the active ingredients are the same.

Generics have gradually inched up 22% of the prescription market in 1985 to 47% of a much larger market in 2002. Total world generic drugs were valued at $38 billion. The generics industry is facing a period of unprecedented growth, with $82 billion worth of global blockbusters set to face patent expiry by 2007. Brand and generics companies alike must be prepared for this new competition. With 79.7% of 2003 blockbuster sales potentially exposed to generic competition by 2010, equating to $103.7 billion worth of products at 2003 sales value, the growth opportunities in the generics sector are significant.

This news release is entirely a personal opinion. It should not be misconstrued as a medical advice.

-----------------------------------------------------------------------------